NICE’s decision for Aimovig for the prevention of migraine 26 September 2019

  NATIONAL MIGRAINE CENTRE’S RESPONSE TO THE NICE DECISION FOR AIMOVIG® (ERENUMAB) FOR THE PREVENTION OF MIGRAINE     Dr David Bloomfield, CEO at the National Migraine Centre, said “We are saddened to learn that the new migraine treatment Aimovig (Erenumab) from Novartis has not been approved by NICE for use within the NHS in […]



Seven Tips to Help Manage Migraines and Mental Health 01 September 2019

                  Mindfulness– there is good evidence that mindfulness can be useful in the pain phase of migraine as well as helping to manage anxiety and depression. Guided apps can be used like ‘Calm’ or ‘Breathing Zone’.   Exercise– exercise can be good for anxiety and depression and […]



Mind Matters In Migraine 01 September 2019

  PRESS RELEASE   NEW SURVEY REVEALS ALMOST 1 IN 4 PEOPLE HAVE EXPERIENCED SUICIDAL FEELINGS OR HAVE SELF HARMED LINKED TO THEIR MIGRAINE/HEADACHE CONDITION     London, 12 August, 2019: Migraines/ headache conditions may have a direct impact on a person’s mental health. 84% of migraine sufferers say that their migraines affect their mental […]